Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2023 Earnings
WINT+
7
Aug
Expected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-13
-8.74
-4.47
-0.21
Details
Expected EPS
-0.68
Actual EPS
-1.64
Surprise EPS
-0.96
Surprise Percent
+141.18%
Description
Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -1.64 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login